default author photo

Cyril Quivoron

Gustave Roussy - Translational Research Hematological Laboratory

Villejuif

France

SCHOLARLY PAPERS

1

DOWNLOADS

63

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Sequence Analyses of Relapsed or Refractory Diffuse Large B-Cell Lymphomas Unravels Three Genetic Subgroups of Patients and GNA3 Mutant as Poor Prognosis Biomarker, Results of LNH-EP1 Study

Number of pages: 35 Posted: 14 Mar 2022
Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Translational Research Hematological Laboratory, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Medical Imaging Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Medical Imaging Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Hematology Department, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), INSERM U1170, Université Paris-Saclay, Gustave Roussy, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Translational Research Hematological Laboratory and Gustave Roussy - Drug Development Department (DITEP)
Downloads 63 (933,592)

Abstract:

Loading...

Lymphoma large B-cell diffuse, Molecular sequencing, Prognosis biomarker, Genetic cluster analysis, Guanine nucleotide binding protein (G protein) alpha 13 human